Skip to content

To study the effectiveness of surgical treatment in patients with knee joint pain

A Post Market Clinical Follow-up (PMCF) study to evaluate the Safety and Performance of Knee Arthroscopy System

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060753
Enrollment
60
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S833- Tear of articular cartilage of knee, current

Interventions

Intervention1: Knee Arthroscope: Patients will be followed up till 12 months after the surgery. Control Intervention1: NIL: NIL

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject is willing and able to give Written informed consent for participation in the study. No history of surgery on affected knee Male or Female, aged between 18 to 75 years and skeletally mature patient. Subject scheduled for Knee arthroscopic surgery for fixation of Knee related ligaments and tendons

Exclusion criteria

Exclusion criteria: Subjects with a disease entity or condition that could hindered healing and create unacceptable risk of fixation failure or complications such as known active cancer, neuromuscular disorder etc. In case, subject has inadequate tissue coverage of the operative sight. Subjects with substance abuse/alcohol issues. Subjects who are incarcerated or have pending incarceration. Subjects with mental disorders Female participant who is pregnant or planning pregnancy during the course of the study. Subject who has contraindication mentioned in the IFU

Design outcomes

Primary

MeasureTime frame
Radiologic Evaluation by X-ray radiographs to observe the healing of tendon and ligaent repair after knee arthroscopy Evaluation of functional performance from baseline to last follow up by recording the Knee Injury and Osteoarthritis Outcome scoreTimepoint: Follow up time points - 1, 3, 6 and 12 Months

Secondary

MeasureTime frame
Secondary Endpoints Follow-up of the patient recovery by analysing visual analogue score (VAS score) for pain assessment Evaluation of Safety of Device by record of any adverse event, serious adverse event and complication during follow up, especially the one mentioned in the Instruction of Use. (IFU)Timepoint: At 1, 3, and 6 months

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Pvt Ltd

clinical2@auxeinmedical.com9419660141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026